Back to Results
First PageMeta Content
Pharmaceuticals policy / Pharmacology / Pharmaceutical industry / Food and Drug Administration / Research exemption / Drug Price Competition and Patent Term Restoration Act / Generic drug / Merck KGaA v. Integra Lifesciences I /  Ltd. / Term of patent in the United States / Law / Pharmaceutical sciences / Patent law


20 Trends in the U.S. Pro - Patent Policy in the Pharmaceutical and Biotechnology Fields ―Focusing on the Hatch-Waxman Act― Short-term Overseas Research Fellow: Toshihiko Asano(*)
Add to Reading List

Document Date: 2009-12-27 21:06:45


Open Document

File Size: 347,82 KB

Share Result on Facebook

Company

IIP Bulletin 2006 Integra LifeSciences I Ltd. / Infigen Inc. / Rhone-Poulenc Rorer / AbTox Inc. / Merck KgaA / Medtronic Inc. / Consideration In Merck KGaA / Ventritex Inc. / Intermedics Inc. / Advanced Cell Technology Inc. / Eli Lilly and Co. / Bristol-Myers Squibb Co. / Exitron Corporation / Integra LifeSciences I Ltd. / Astellas Pharma Inc. / Pfizer / Dole / Appeals / Teva / Mylan Pharmaceuticals Inc. / Elite Pharmaceuticals Inc. / /

Country

Japan / United States / /

Currency

USD / /

Event

FDA Phase / Patent Issuance / /

Facility

Duke University / Scripps Research Institute / Court Decisions Determining court / /

IndustryTerm

drug product / end products / law experimental use exception / technology development / drug manufacturer / law doctrine / case law / generic drug manufacturer / manufacturing new drugs / metabolic product / information technology / human drug product / food additives / drug products / oil crises / law exemption / law experimental use exemption / file applications / biotechnology fields / manufacturing approval / pharmaceutical / conversion algorithm / micro-array technology / assay research tool / recombinant human product / patent law / pharmaceutical compounds / /

Organization

House of Representatives / Supreme Court / Federal Trade Commission / Medicare / Duke University / US Supreme Court / Representative court / Court of Appeals / Japanese government / FDA / Japanese Supreme Court / Board of Appeals / Currently Intellectual Property Department / Court Decisions Determining court / Food and Drug Administration / District Court / Intellectual Property High Court / Pharmaceutical Manufacturers Association / Congress / UN Court / Generic Pharmaceutical Industry Association / Scripps Research Institute / /

Person

Newman / Toshihiko Asano / Newman Judge / Waxman (Democrat) / Rader / Orrin G. Hatch / Henry A. Waxman / Bush / Koizumi / Mike Synar / Charles McCurdy Jr. / Reddy / Lincoln / Mathias / /

Position

Prime Minister / President / representative / Assistant Attorney General / Fisher / Judge / /

Product

Federal Food / Medicare Prescription Drug / FDA / /

ProvinceOrState

Indiana / /

PublishedMedium

the IIP Bulletin / /

Technology

information technology / gene expression / micro-array technology / conversion algorithm / Biotechnology / drug development / /

SocialTag